These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 5408017)
41. Molecular modeling of the interaction of LSD and other hallucinogens with 5-HT2 receptors. Westkaemper RB; Glennon RA NIDA Res Monogr; 1994; 146():263-83. PubMed ID: 8742803 [No Abstract] [Full Text] [Related]
42. [Psychedelic drugs]. Kuiper PC Ned Tijdschr Geneeskd; 1968 Oct; 112(41):1867-9. PubMed ID: 5685652 [No Abstract] [Full Text] [Related]
43. [Problems of psychotoxicology (a review of the literature)]. Spivak LI; Mil'shteĭn GI Voen Med Zh; 1973 Oct; 10():40-4. PubMed ID: 4786146 [No Abstract] [Full Text] [Related]
44. Psychotomimetic agents. Cohen S Annu Rev Pharmacol; 1967; 7():301-18. PubMed ID: 5337083 [No Abstract] [Full Text] [Related]
45. Effects of lysergic acid diethylamide on attack behavior of male albino mice. Uyeno ET; Benson WM Psychopharmacologia; 1965 Jan; 7(1):20-6. PubMed ID: 5890567 [No Abstract] [Full Text] [Related]
46. Effects of cannabis sativa and LSD on pigeons in three visual environments. Siegel RK Percept Mot Skills; 1970 Apr; 30(2):510. PubMed ID: 5454055 [No Abstract] [Full Text] [Related]
47. Effects of Cannabis sativa and lysergic acid diethylamide on a visual discrimination task in pigeons. Siegel RK Psychopharmacologia; 1969; 15(1):1-8. PubMed ID: 5352137 [No Abstract] [Full Text] [Related]
48. Psychedelics - Re-opening the doors of perception. Heal DJ; Henningfield J; Frenguelli BG; Nutt DJ; Smith SL Neuropharmacology; 2018 Nov; 142():1-6. PubMed ID: 30144477 [No Abstract] [Full Text] [Related]
49. Dynamics of psychedelic drug abuse. A clinical study. Bowers M; Chipman A; Schwartz A; Dann OT Arch Gen Psychiatry; 1967 May; 16(5):560-6. PubMed ID: 5337259 [No Abstract] [Full Text] [Related]
50. Effects of cannabis resin on social behaviour in the laboratory mouse. Cutler MG; Mackintosh JH; Chance MR Psychopharmacologia; 1975; 41(3):271-6. PubMed ID: 1171494 [TBL] [Abstract][Full Text] [Related]
51. Evaluation of 3,4-methylenedioxyamphetamine (MDA) as an adjunct to psychotherapy. Naranjo C; Shulgin AT; Sargent T Med Pharmacol Exp Int J Exp Med; 1967; 17(4):359-64. PubMed ID: 5631047 [No Abstract] [Full Text] [Related]
52. The alienated, older, isolated male adolescent. Teicher JD Am J Psychother; 1972 Jul; 26(3):401-7. PubMed ID: 5037778 [No Abstract] [Full Text] [Related]
53. Ketamine and the conscious mind. Collier BB Anaesthesia; 1972 Apr; 27(2):120-34. PubMed ID: 5021517 [No Abstract] [Full Text] [Related]
54. Effects of (--)delta-9-trans-tetrahydrocannabinol in man. Isbell H; Gorodetzsky CW; Jasinski D; Claussen U; von Spulak F; Korte F Psychopharmacologia; 1967; 11(2):184-8. PubMed ID: 4871478 [No Abstract] [Full Text] [Related]
55. Repression of death consciousness and the psychedelic trip. Dutta V J Cancer Res Ther; 2012; 8(3):336-42. PubMed ID: 23174711 [TBL] [Abstract][Full Text] [Related]
56. Effects of cannabis drugs on social behaviour of laboratory rodents. Frischknecht HR Prog Neurobiol; 1984; 22(1):39-58. PubMed ID: 6374764 [No Abstract] [Full Text] [Related]
57. Persistence of biochemical effect. Sattin A Am J Psychiatry; 1969 Feb; 125(8):1129-30. PubMed ID: 5794856 [No Abstract] [Full Text] [Related]